Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-07-03 Tax Withholding | 2023-07-06 5:20 pm | N/A N/A | Talaris Therapeutics Inc. | TALS | Fenton Mary Kay Chief Financial Officer | 12,946 | $3.08 | 68,054 (Direct) | View |
| 2023-02-01 Option Award | 2023-02-03 4:57 pm | N/A 2033-02-01 | Talaris Therapeutics Inc. | TALS | Fenton Mary Kay Chief Financial Officer | 300,000 | $0 | 300,000 (Direct) | View |
| 2022-09-10 Option Award | 2022-09-13 4:29 pm | N/A N/A | Talaris Therapeutics Inc. | TALS | Fenton Mary Kay Chief Financial Officer | 80,000 | $0 | 81,000 (Direct) | View |
| 2022-06-23 Option Award | 2022-06-24 06:44 am | N/A 2032-06-23 | Oncorus Inc. | ONCR | Fenton Mary Kay Director | 12,500 | $0 | 12,500 (Direct) | View |
| 2022-02-01 Option Award | 2022-02-02 6:00 pm | N/A 2032-01-31 | Talaris Therapeutics Inc. | TALS | Fenton Mary Kay Chief Financial Officer | 200,000 | $0 | 201,000 (Direct) | View |
| 2021-12-31 Option Award | 2022-02-02 6:00 pm | N/A N/A | Talaris Therapeutics Inc. | TALS | Fenton Mary Kay Chief Financial Officer | 1,000 | $13 | 201,000 (Direct) | View |
| 2021-06-16 Option Award | 2021-06-17 5:57 pm | N/A 2031-06-15 | Oncorus Inc. | ONCR | Fenton Mary Kay Director | 12,500 | $0 | 12,500 (Direct) | View |
Ownership | 2021-05-06 9:14 pm | N/A 2031-02-21 | Talaris Therapeutics Inc. | TALS | Fenton Mary Kay Chief Financial Officer | 0 | $0 | 364,485 (Direct) | View |
Ownership | 2020-10-01 7:04 pm | N/A 2029-12-18 | Oncorus Inc. | ONCR | Fenton Mary Kay Director | 0 | $0 | 9,927 (Direct) | View |